Kalafatis et al., 2002 - Google Patents
Identification of a binding site for blood coagulation factor Xa on the heavy chain of factor Va. Amino acid residues 323− 331 of factor V represent an interactive site for …Kalafatis et al., 2002
- Document ID
- 6070586439647278082
- Author
- Kalafatis M
- Beck D
- Publication year
- Publication venue
- Biochemistry
External Links
Snippet
We have recently shown that amino acid region 307− 348 of factor Va heavy chain (42 amino acids, N42R) is critical for cofactor activity and may contain a binding site for factor Xa and/or prothrombin [(2001) J. Biol. Chem. 276, 18614− 18623]. To ascertain the importance …
- 108010074105 Factor Va 0 title abstract description 448
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kalafatis et al. | Identification of a binding site for blood coagulation factor Xa on the heavy chain of factor Va. Amino acid residues 323− 331 of factor V represent an interactive site for activated factor X | |
| Pechik et al. | Structural basis for sequential cleavage of fibrinopeptides upon fibrin assembly | |
| Middendorp et al. | Peptide macrocycle inhibitor of coagulation factor XII with subnanomolar affinity and high target selectivity | |
| Wakabayashi et al. | Metal ion-independent association of factor VIII subunits and the roles of calcium and copper ions for cofactor activity and inter-subunit affinity | |
| Kirchhofer et al. | The tissue factor region that interacts with factor Xa in the activation of factor VII | |
| Arosio et al. | Mutation of W215 compromises thrombin cleavage of fibrinogen, but not of PAR-1 or protein C | |
| Chen et al. | Functional and sequence characterization of coagulation factor IX/factor X-binding protein from the venom of Echis carinatus leucogaster | |
| Croy et al. | Allosteric changes in solvent accessibility observed in thrombin upon active site occupation | |
| Rudolph et al. | Substitution of asparagine for arginine 347 of recombinant factor Xa markedly reduces factor Va binding | |
| Sabo et al. | Conformational Analysis of γ ‘Peptide (410− 427) Interactions with Thrombin Anion Binding Exosite II | |
| Kolkman et al. | Insertion loop 256− 268 in coagulation factor IX restricts enzymatic activity in the absence but not in the presence of factor VIII | |
| Donate et al. | Dimerization of tissue factor supports solution-phase autoactivation of factor VII without influencing proteolytic activation of factor X | |
| Jenkins et al. | Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase | |
| Spiegel et al. | Surface-exposed hemophilic mutations across the factor VIII C2 domain have variable effects on stability and binding activities | |
| Rezaie et al. | Thrombomodulin increases the rate of thrombin inhibition by BPTI | |
| Wakabayashi et al. | Identification of residues contributing to A2 domain-dependent structural stability in factor VIII and factor VIIIa | |
| Sudhakar et al. | Effects of copper on the structure and function of factor VIII subunits: evidence for an auxiliary role for copper ions in cofactor activity | |
| Ally et al. | Characterization of the specificity of arginine-specific gingipains from Porphyromonas gingivalis reveals active site differences between different forms of the enzymes | |
| Regan et al. | Activated Protein C-catalyzed Proteolysis of Factor VIIIa Alters Its Interactions within Factor Xase (∗) | |
| Parker et al. | Subunit structure and function of porcine factor Xa-activated factor VIII | |
| Mochalkin et al. | Recombinant kringle IV-10 modules of human apolipoprotein (a): structure, ligand binding modes, and biological relevance | |
| Rezaie et al. | Contribution of lysine 60f to S1 ‘specificity of thrombin | |
| London et al. | Annexin V inhibition of factor IXa-catalyzed factor X activation on human platelets and on negatively-charged phospholipid vesicles | |
| Richardson et al. | Characterization of the Residues Involved in the Human α-Thrombin− Haemadin Complex: An Exosite II-Binding Inhibitor | |
| Betz et al. | Inhibition of factor Xa by a peptidyl-α-ketothiazole involves two steps. Evidence for a stabilizing conformational change |